Nine-month presence of SARS-CoV-2 in saliva: a case report
Jansen, G. J.; Wiersma, M.
Show abstract
SARS-CoV-2 is a novel coronavirus that mainly affects the upper airways. Approximately one third of all detected cases is asymptomatic. We report an asymptomatic individual who tested positive for SARS-CoV-2 over a period of nine months. Of this individual, whole mouth saliva was tested by a novel fluorescence in situ hybridization-based assay which detects only the active form of the virus. During the observation period of nine months, there was a possible co-infection with a second SARS-CoV-2 variant accompanied by none or very low antibody production until the possible co-infection. We suspect that the SARS-CoV-2 infection in this individual is limited to the salivary glands and does not spread (much) throughout the systemic compartment(s) of the body.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Real-life performance of a novel antigen detection test on nasopharyngeal specimens for SARS-CoV-2 infection diagnosis: a prospective study 93%
- Saliva as a potential clinical specimen for diagnosis of SARS-CoV-2 93%
- Evaluation Of A New “All In One” Sars-Cov-2 Antigen-Detecting Rapid Diagnostic Test And Self-Test: Diagnostic Performance And Usability On Child And Adult Population 93%
Similar papers in this journal
- Evaluation of saliva molecular point of care for detection of SARS-CoV-2 in ambulatory care 93%
- A simple RNA preparation method for SARS-CoV-2 detection by RT-qPCR 92%
- Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for a pandemic-scale infection surveillance 92%
Similar papers in this journal
- Clinical evaluation of the Roche/SD Biosensor rapid antigen test with symptomatic, non-hospitalized patients in a municipal health service drive-through testing site 92%
- Large-scale screening of asymptomatic for SARS-CoV-2 variants of concern and rapid P.1 takeover, Curitiba, Brazil 92%
- Saliva offers a sensitive, specific and non-invasive alternative to upper respiratory swabs for SARS-CoV-2 diagnosis. 91%
Similar papers in this journal
- Evaluation of GENECUBE ® HQ SARS-CoV-2 for anterior nasal samples and saliva samples with a new rapid examination protocol 93%
- Diagnostic Accuracy Of Non-Invasive Detection Of SARS-COV-2 Infection By Canine Olfaction 93%
- Development and validation of a highly sensitive and specific electrochemical assay to quantify anti-SARS-CoV-2 IgG antibodies to facilitate pandemic surveillance and monitoring of vaccine response 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.